advertisement
Takai Y 14
Showing records 1 to 14 | Display all abstracts from Takai Y91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Inatani M
Advances in Therapy 2021; 38: 1106-1115
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Takayanagi Y
Life (Basel, Switzerland) 2020; 10:
90953 Evaluation of Redox Profiles of the Serum and Aqueous Humor in Patients with Primary Open-Angle Glaucoma and Exfoliation Glaucoma
Takayanagi Y; Takayanagi Y
Antioxidants (Basel, Switzerland) 2020; 9:
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Takayanagi Y
Life (Basel, Switzerland) 2020; 10:
90953 Evaluation of Redox Profiles of the Serum and Aqueous Humor in Patients with Primary Open-Angle Glaucoma and Exfoliation Glaucoma
Takai Y
Antioxidants (Basel, Switzerland) 2020; 9:
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Takai Y
Life (Basel, Switzerland) 2020; 10:
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Higashide T
Advances in Therapy 2021; 38: 1106-1115
90953 Evaluation of Redox Profiles of the Serum and Aqueous Humor in Patients with Primary Open-Angle Glaucoma and Exfoliation Glaucoma
Kaidzu S
Antioxidants (Basel, Switzerland) 2020; 9:
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Matsushita K
Advances in Therapy 2021; 38: 1106-1115
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Kaidzu S
Life (Basel, Switzerland) 2020; 10:
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Nagasato D
Advances in Therapy 2021; 38: 1106-1115
91515 Association between Systemic Antioxidant Capacity and Retinal Vessel Diameters in Patients with Primary-Open Angle Glaucoma
Tanito M
Life (Basel, Switzerland) 2020; 10:
90953 Evaluation of Redox Profiles of the Serum and Aqueous Humor in Patients with Primary Open-Angle Glaucoma and Exfoliation Glaucoma
Tanito M
Antioxidants (Basel, Switzerland) 2020; 9:
91677 Efficacy and Safety of Intravitreal Aflibercept Injection in Japanese Patients with Neovascular Glaucoma: Outcomes from the VENERA Study
Takagi H; Ueki M; Takai Y; Miyazaki K; Iwamoto Y; Kobayashi M; Leal S; Leal S
Advances in Therapy 2021; 38: 1106-1115
